; (2) ascertain, evaluate, and report on the evidence developed by any relevant governmental and nongovernmental entities regarding the facts and circumstances surrounding COVID–19; (3) make a full and complete assessment and accounting of the preparedness of the Federal Government, State governments, local governments, and the private sector for the outbreak and spread of COVID–19 in the United States; (4) make a full and complete assessment and accounting of the actions by the Federal Government, State governments, local governments, and the private sector in response to the outbreak and spread of COVID–19 in the United States; and (5) investigate and report to the President, Congress, and the public on its findings, conclusions, and recommendations to improve the ability of the United States to prepare for, detect, prevent, and, if necessary, respond to epidemics and pandemics such as COVID–19, whether naturally occurring or caused by State or non-State actors. (c) Composition of Commission (1) Members The Commission shall be composed of 10 members, of whom— (A) 1 member shall be appointed by the President, who shall serve as chair of the Commission; (B) 1 member shall be appointed by the leaders of the Senate (majority or minority leader, as the case may be) of the political party that is not the same political party as the President, in consultation with the leader of the House of Representatives (majority or minority leader, as the case may be) of the same political party as such Senate leaders, who shall serve as vice chair of the Commission; (C) 2 members shall be appointed by the senior member of the Senate leadership of the Democratic Party; (D) 2 members shall be appointed by the senior member of the leadership of the House of Representatives of the Republican Party; (E) 2 members shall be appointed by the senior member of the Senate leadership of the Republican Party